MED19/LCMR1 Polyclonal Antibody, Biotin Conjugated
Product Specifications
Background
MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]) .[supplied by OMIM, Oct 2008]
Synonyms
LCMR1; Lung cancer metastasis related protein 1; Lung cancer metastasis-related protein 1; med19; MED19_HUMAN; Mediator complex subunit 19; Mediator of RNA polymerase II transcription subunit 19; Mediator of RNA polymerase II transcription, subunit 19 homolog.
Gene ID
219541
Swiss Prot
A0JLT2
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Rat
Immunogen
51-150/244
Target
MED19
Clonality
Polyclonal
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from human MED19/LCMR1
Applications
ELISA, IHC-P, IHC-F
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
219541
Predicted Cross Reactivity
Human, Mouse, Cow, Horse, Chicken
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
133081-ML750 100 µL
SEC22B (SEC22 Vesicle-trafficking Protein Homolog B, Vesicle-trafficking Protein SEC22b, ER-Golgi SNARE of 24kD, ERS-24, ERS24, SEC22 Vesicle-trafficking Protein-like 1, SEC22L1) (MaxLight 750) discontinued
Ask
View Details